Alexander Parkhomenko

Alexander Parkhomenko

UNVERIFIED PROFILE

Are you Alexander Parkhomenko?   Register this Author

Register author
Alexander Parkhomenko

Alexander Parkhomenko

Publications by authors named "Alexander Parkhomenko"

Are you Alexander Parkhomenko?   Register this Author

69Publications

4685Reads

24Profile Views

Trimetazidine in cardiovascular medicine.

Int J Cardiol 2019 10 24;293:39-44. Epub 2019 May 24.

Cardiovascular and Cell Sciences Research Institute, St George's University, London, UK; IRCCS San Raffaele Pisana, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2019.05.063DOI Listing
October 2019

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

N Engl J Med 2019 04 17;380(16):1509-1524. Epub 2019 Mar 17.

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L., G.H., A.N.V., T.M., C.B.G., J.H.A.); Bristol-Myers Squibb, Princeton, NJ (R.A., J.L.); Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, and Cardiovascular Research Foundation, New York (R.M.); Canadian VIGOUR Centre, University of Alberta, Edmonton (S.G.G.), and the Terrence Donnelly Heart Centre, St. Michael's Hospital, University of Toronto, Toronto (S.G.G.) - both in Canada; Swiss Cardiovascular Center, Bern, Switzerland (S.W.); Vivantes Neukoelln Medical Center, Berlin (H.D.), and Heart Center Leipzig, Department of Internal Medicine-Cardiology, University of Leipzig, Leipzig (H.T.) - both in Germany; Pirogov Russian National Research Medical University, Moscow (O.A.); Instituto de Neurología Cognitiva (INECO) Neurociencias Oroño, Fundación INECO, Rosario, Argentina (M.C.B.); Hospital Israelita Albert Einstein, São Paulo (O.B.); Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); the Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (Z.H.); the National Scientific Center, Strazhesko Institute of Cardiology, Kiev, Ukraine (A.P.); University Hospitals Leuven, University of Leuven, Leuven, Belgium (P.S.); the Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom (R.F.S.); and University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania (D.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1817083DOI Listing
April 2019

Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.

J Am Coll Cardiol 2018 02;71(5):489-496

Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar and Dutch Network for Cardiovascular Research (WCN), the Netherlands; Department of Cardiology, CWZ Hospital, Nijmegen, the Netherland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2017.11.050DOI Listing
February 2018

Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension.

Hypertension 2018 01 30;71(1):168-176. Epub 2017 Oct 30.

From the Cardiology and Physiology Departments, Département Hospitalo-Universitaire FIRE, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat and Paris Diderot University, Sorbonne Paris Cité, France (E.V.-P., P.G.S.); INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France (E.V.-P.); Robertson Centre for Biostatistics, University of Glasgow, United Kingdom (N.G., I.F.); Centro Cardiologico Universitario di Ferrara, University of Ferrara, and Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy (R.F.); National Heart and Lung Institute, Imperial College, Institute of Cardiovascular Medicine and Science, Royal Brompton Hospital, London, United Kingdom (K.M.F., P.G.S.); Department of Medicine, Montreal Heart Institute, Université de Montreal, Canada (J.-C.T.); Medical University of Silesia, School of Medicine in Katowice, Department of Cardiology and Structural Heart Disease, Poland (M.T.); Emergency Cardiology Department, Institute of Cardiology, Kiev, Ukraine (A.P.); Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (D.L.B.); and French Alliance for Cardiovascular Trials, an F-CRIN network, INSERM U1148, Laboratory for Vascular Translational Science, Paris, France (P.G.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10204DOI Listing
January 2018

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

N Engl J Med 2017 10 27;377(14):1319-1330. Epub 2017 Aug 27.

From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (J.W.E., S.J.C., J.B., R.G.H., O.S., E.M.L., S.S.A., D.L., S.Y.), and Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, QC (G.R.D.) - both in Canada; Estudios Clínicos Latino América and Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Amphia Ziekenhuis and Werkgroep Cardiologische Centra Nederland (WCN), Utrecht, the Netherlands (M.A.); Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic (P.W.); Osaka International Cancer Institute, Osaka, Japan (M.H.); Instituto Dante Pazzanese de Cardiologia (A.A.), and Hospital do Coração (L.S.P.), São Paulo; University of Washington Medical Center (K.R.H.B.) and University of Washington (J.P.), Seattle; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston (D.L.B.); FuWai Hospital, Beijing (J.Z., Y.L.); National Association of Hospital Cardiologists Research Center (ANMCO), Florence, Italy (A.P.M.); Research Institute, Fundación Oftalmológica de Santander (FOSCAL)-Bucaramanga, Bucaramanga, Colombia (P.L.-J.); National University of Ireland, Galway (M.O.); Thrombosis Research Institute and University College London, London (A.K.K.), Centre for Cardiovascular Science, University of Edinburgh, Edinburgh (K.A.A.F.), and University of Glasgow, Glasgow (T.J.G.) - all in the United Kingdom; Collegium Medicum Jagiellonian University, Krakow, Poland (T.J.G); Institute of Cardiology, Kiev, Ukraine (A.N.P.); University of Würzburg and University Hospital, Würzburg (G.E., S.S.), and Bayer, Leverkusen (N.C.B., F.M., E.C.) - all in Germany; Semmelweis University, Budapest, Hungary (M.K.); Karolinska Institutet, Stockholm (L.R.); National Research Center for Preventative Medicine, Moscow (N.P.); University of Philippines, Manila (A.L.D.); Universidad de La Frontera, Temuco, Chile (F.L.); University of Cape Town, Cape Town, South Africa (P.J.C.); University of Aalborg, Copenhagen (C.T.-P.); University of Leuven, Leuven, Belgium (P.B.V.); University of Medicine and Pharmacology, Carol Davila University and Emergency Hospital, Bucharest, Romania (D.V.); Catholic University of Korea, Seoul, South Korea (J.-H.K.); Monash University, Melbourne, VIC, Australia (A.M.T.); Lady Davis Carmel Medical Center, Haifa, Israel (B.S.L.); Facultad de Ciencias de la Salud Eugenio Espejo-Universidad Tecnológica Equinoccial, Quito, Ecuador (C.F.); Universiti Teknologi Mara, Selangor, Malaysia (K.Y.); Université Paris Diderot, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris (P.G.S.); and Turku University Central Hospital and Turku University, Turku, Finland (K.P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709118DOI Listing
October 2017

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

N Engl J Med 2016 May 2;374(21):2032-43. Epub 2016 Apr 2.

From the Population Health Research Institute, Hamilton Health Sciences (S.Y., E.L., J.B., R.M., J.P., H.J.), Department of Medicine (S.Y., E.L., R.M.), School of Rehabilitation Science (J.B.), Department of Clinical Epidemiology and Biostatistics (J.P.), McMaster University, Hamilton, ON, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.), and Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Quebec, QC (G.D.) - all in Canada; St. John's Research Institute (P.P., D.X.), and St. John's Medical College (D.X.), Bangalore, India; Fundacion Oftalmológica de Santander and Instituto Masira, Medical School, Universidad de Santander, Bucaramanga (P.L.-J.), and Universidad del Norte, Barranquilla (J.L.A.) - both in Colombia; Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (J.Z., L.L.); Dante Pazzanese Institute of Cardiology (A.A.) and HCor-Heart Hospital (L.S.P.), Sao Paulo; Institute of Cardiology, Kiev, Ukraine (A.P.); Hungarian Institute of Cardiology, Semmelweis University, Budapest, Hungary (M.K., K. Keltai); Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town, Soweto Cardiovascular Research Group, Cape Town, South Africa (K.S.); Institute of Clinical Cardiology in the Russian Cardiology Research Complex, Moscow (I.C.); the Department of Cardiology, Academic Medical Center, Amsterdam (R.J.G.P.); the Department of Medical Sciences, Cardiology, Clinical Research Center, Uppsala University, Uppsala, Sweden (C.H.); Universiti Teknologi Majlis Amansh Rakyat, Selayang, and University College Sedaya International University, Kuala Lumpur (K.Y.) - both in Malaysia; Lady Davis Carmel Medical Center, Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel (B.S.L.); University Hospital Motol, Prague, Czech Repu

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1600177DOI Listing
May 2016

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

N Engl J Med 2016 May 2;374(21):2021-31. Epub 2016 Apr 2.

From the Population Health Research Institute, Hamilton Health Sciences (S.Y., J.B., R.M., J.P., H.J., P.G., E.L.), Departments of Medicine (S.Y., R.M., E.L.) and Clinical Epidemiology and Biostatistics (J.P.), and School of Rehabilitation Science (J.B.), McMaster University, Hamilton, ON, Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Quebec, QC (G.D.), and Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - all in Canada; Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (J.Z., L.L.); St. John's Medical College (D.X.) and St. John's Research Institute (D.X., P.P.), Bangalore, India; Fundacion Oftalmológica de Santander and Instituto Masira, Medical School, Universidad de Santander, Bucaramanga (P.L.-J.), and University of Quindio, Armenia (G.S.-V.) - both in Colombia; College of Medicine, University of the Philippines, Manila (A.D.); Dante Pazzanese Institute of Cardiology (A.A.) and HCor-Heart Hospital (L.S.P.), São Paulo; Institute of Cardiology, Kiev, Ukraine (A.P.); Hungarian Institute of Cardiology, Semmelweis University, Budapest (K. Keltai, M.K.); Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town, Soweto Cardiovascular Research Group, Cape Town, South Africa (K.S.); Department of Cardiology, Academic Medical Center, Amsterdam (R.J.G.P); Department of Medical Sciences, Cardiology, Clinical Research Center, Uppsala University, Uppsala, Sweden (C.H.); Institute of Clinical Cardiology in the Russian Cardiology Research Complex, Moscow (I.C.); Universiti Teknologi Majlis Amansh Rakyat, Selayang, and University College Sedaya International University, Kuala Lumpur - both in Malaysia (K.Y.); Lady Davis Carmel Medical Center, Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa (B.S.L.); Universi

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1600176DOI Listing
May 2016

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

N Engl J Med 2016 May 2;374(21):2009-20. Epub 2016 Apr 2.

From the Population Health Research Institute, Hamilton Health Sciences (E.M.L., J.B., R.M., J.P., J.W., H.J., S.Y.), the Department of Medicine (E.M.L., R.M., S.Y.), the School of Rehabilitation Science (J.B.), and the Department of Clinical Epidemiology and Biostatistics (J.P.), McMaster University, Hamilton, ON, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.), and Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Quebec, QC (G.D.) - all in Canada; Fundacion Oftalmológica de Santander and Instituto Masira, Medical School, Universidad de Santander, Bucaramanga (P.L.-J.), and University of Caldas and Institución Prestadora de Salud Internistas de Caldas, Manizales (D.I.M.S.) - both in Colombia; Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (J.Z., L.L.); St. John's Research Institute (P.P., D.X.) and St. John's Medical College (D.X.), Bangalore, India; Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town, Soweto Cardiovascular Research Group, Cape Town, South Africa (K.S.); College of Medicine, University of the Philippines, Manila (A.D.); Dante Pazzanese Institute of Cardiology (A.A.) and HCor-Heart Hospital (L.S.P.) - both in São Paulo; Hungarian Institute of Cardiology, Semmelweis University, Budapest, Hungary (K. Keltai, M.K.); Institute of Clinical Cardiology in the Russian Cardiology Research Complex, Moscow (I.C.); the Department of Cardiology, Academic Medical Center, Amsterdam (R.J.G.P.); the Department of Medical Sciences, Cardiology, Clinical Research Center, Uppsala University, Uppsala, Sweden (C.H.); Universiti Teknologi Majlis Amansh Rakyat, Selayang, and University College Sedaya International University, Kuala Lumpur (K.Y.) - both in Malaysia; Lady Davis Ca

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1600175DOI Listing
May 2016

The strengths and limitations of the Ukrainian healthcare system.

Eur Heart J 2013 Dec;34(45):3465-6

View Article

Download full-text PDF

Source
December 2013

Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial.

Eur J Heart Fail 2013 Feb 7;15(2):221-7. Epub 2012 Aug 7.

INSERM, Center of Clinical Investigation 9501, Lorraine Institute of Heart and Vessels Louis Mathieu, University Hospital Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurjhf/hfs128DOI Listing
February 2013

Association of matrix Gla protein gene allelic polymorphisms (G(-7)→A, T(-138)→C and Thr(83)→Ala) with acute coronary syndrome in the Ukrainian population.

Exp Clin Cardiol 2012 ;17(1):30-3

Department of Physiology and Physiopathology and Medical Biology, Sumy State University, Sumy; Department of General and Molecular Pathophysiology, Bogomoletz Institute of Physiology, National Academy of Science, Kiev; National Scientific Center "M.D. Strazhesko Institute of Cardiology", National Medical Academy of Science, Kiev, Ukraine.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383365PMC
December 2012

Third universal definition of myocardial infarction.

Authors:
Kristian Thygesen Joseph S Alpert Allan S Jaffe Maarten L Simoons Bernard R Chaitman Harvey D White Kristian Thygesen Joseph S Alpert Harvey D White Allan S Jaffe Hugo A Katus Fred S Apple Bertil Lindahl David A Morrow Bernard R Chaitman Peter M Clemmensen Per Johanson Hanoch Hod Richard Underwood Jeroen J Bax Jeroen J Bonow Fausto Pinto Raymond J Gibbons Keith A Fox Dan Atar L Kristin Newby Marcello Galvani Christian W Hamm Barry F Uretsky Ph Gabriel Steg William Wijns Jean-Pierre Bassand Phillippe Menasche Jan Ravkilde E Magnus Ohman Elliott M Antman Lars C Wallentin Paul W Armstrong Maarten L Simoons James L Januzzi Markku S Nieminen Mihai Gheorghiade Gerasimos Filippatos Russell V Luepker Stephen P Fortmann Wayne D Rosamond Dan Levy David Wood Sidney C Smith Dayi Hu Jose-Luis Lopez-Sendon Rose Marie Robertson Douglas Weaver Michal Tendera Alfred A Bove Alexander N Parkhomenko Elena J Vasilieva Shanti Mendis Jeroen J Bax Helmut Baumgartner Claudio Ceconi Veronica Dean Christi Deaton Robert Fagard Christian Funck-Brentano David Hasdai Arno Hoes Paulus Kirchhof Juhani Knuuti Philippe Kolh Theresa McDonagh Cyril Moulin Bogdan A Popescu Zeljko Reiner Udo Sechtem Per Anton Sirnes Michal Tendera Adam Torbicki Alec Vahanian Stephan Windecker Joao Morais Carlos Aguiar Wael Almahmeed David O Arnar Fabio Barili Kenneth D Bloch Ann F Bolger Hans Erik Botker Biykem Bozkurt Raffaele Bugiardini Christopher Cannon James de Lemos Franz R Eberli Edgardo Escobar Mark Hlatky Stefan James Karl B Kern David J Moliterno Christian Mueller Aleksandar N Neskovic Burkert Mathias Pieske Steven P Schulman Robert F Storey Kathryn A Taubert Pascal Vranckx Daniel R Wagner

J Am Coll Cardiol 2012 Oct 5;60(16):1581-98. Epub 2012 Sep 5.

Department of Cardiology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000 Aarhus C, Denmark.

View Article

Download full-text PDF

Source
http://circ.ahajournals.org/content/126/16/2020.full.pdf+htm
Web Search
http://www.world-heart-federation.org/fileadmin/user_upload/
Web Search
https://eurheartj.oxfordjournals.org/content/ehj/33/20/2551.
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S073510971202896
Publisher Site
http://dx.doi.org/10.1016/j.jacc.2012.08.001DOI Listing
October 2012

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Eur J Heart Fail 2012 Aug;14(8):803-69

Glasgow G12 8QQ, UK.

View Article

Download full-text PDF

Source
http://eurheartj.oxfordjournals.org/content/ehj/33/14/1787.f
Web Search
http://doi.wiley.com/10.1093/eurjhf/hfs105
Publisher Site
http://dx.doi.org/10.1093/eurjhf/hfs105DOI Listing
August 2012

Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.

Cardiology 2011 25;120(2):59-72. Epub 2011 Nov 25.

Department of Coronary Artery Disease and Acute Cardiac Care, Hôpital Européen Georges Pompidou, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000332369DOI Listing
February 2012

Model of SOS-induced mutagenesis in bacteria Escherichia coli under ultraviolet irradiation.

J Theor Biol 2009 Dec 21;261(3):388-95. Epub 2009 Aug 21.

Laboratory of Radiation Biology, Joint Institute for Nuclear Research, 141980 Joliot-Curie 6, Dubna, Moscow Region, Russia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtbi.2009.08.016DOI Listing
December 2009

Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction

Eur J Heart Fail 2006 May 28;8(3):295-301. Epub 2006 Feb 28.

University of Michigan Medical Center, Alfred Taubman Health Care Center, 1500 East Medical Center Drive, Ann Arbor, 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejheart.2005.11.008DOI Listing
May 2006

A view from Ukraine.

Circulation 2006 Apr;113(13):f49-50

Emergency Cardiology Department, National Institute of Cardiology, Kiev, Ukraine.

View Article

Download full-text PDF

Source
April 2006

Additional effects of irbesartan when compared to captopril in the prevention of post-infarction left ventricular dilatation.

Acta Cardiol 2002 Feb;57(1):61-3

Institute of Cardiology, N. D. Strazhesko Ukrainian Academy of Medical Sciences, Kiev.

View Article

Download full-text PDF

Source
February 2002